ETEnrico Tassinari

Enrico Tassinari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Enrico Tassinari has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pre‐operative radiological grading and inflammatory mediators as candidate biomarkers of early joint degeneration in patients with femoroacetabular impingement

    by Eleonora Olivotto, Elisa Bubbico, Alessio Bucciarelli, Andrea Burla, Irene Tampieri, Giorgia Borciani, Stefano Zaffagnini, Enrico Tassinari

    Purpose: The aim of the study was to identify potential biomarkers of pre‐arthritic condition and early osteoarthritis (OA) in patients with femoroacetabular impingement (FAI), by analysing clinical data and quantifying inflammatory molecules, typically involved in OA pathology, in body fluids. Methods: FAI patients undergoing hip arthroscopy were enroled after providing written informed consent. Demographic data (age, sex, body mass index [BMI]) were collected, together with radiographic grading of hip degeneration (Tönnis scale) and intra‐articular pathology grading (Outerbridge classification). Cartilage degradation markers and immunomodulating molecules were quantified by commercially available sandwich‐enzyme‐linked assay and multiplex bead‐based sandwich immunoassay kits. Results: Forty‐nine patients were enroled, 38 synovial fluids (SFs) and urine samples were available. Median age 32 years ± 8.35 standard deviation (SD); median BMI 24 kg/m 2 ± 4.89 SD. Higher BMI corresponded to acetabular chondropathy and was associated with increased C‐telopeptide fragments of Type II collagen (CTX‐II) release in both SFs and urine. Radiological and intra‐operative scores showed moderate‐to‐strong positive correlation with synovial CTX‐II and slight‐to‐strong positive correlation with vascular endothelial growth factor (VEGF). CTX‐II and Cartilage Oligomeric Matrix Protein (COMP) in SFs were positively correlated, showing a high‐to‐moderate positive correlation with VEGF. VEGF demonstrated a high‐to‐moderate positive correlation with interleukin (IL)‐6 and IL‐8. IL1‐β correlates moderately positively with IL‐8, MIP‐3β and TNF‐α, which in turn is linked to the release of 6kine, MIP‐3β and RANTES. Except for IL‐8, all chemokines showed a similar release pattern, suggesting a synergistic and continuous inflammatory mechanism. Conclusions: A higher BMI was associated with increased CTX‐II in both body fluids, suggesting a potential link between metabolic status and early cartilage degradation in FAI patients. Radiographic and intraoperative indicators of joint degeneration were also associated with selected synovial biomarkers (CTX‐II, VEGF, IL‐6, IL‐8). These findings suggest that synovial and urinary biomarkers may represent candidate markers of early joint degeneration in FAI, useful for clinical evaluation of FAI patients at risk of progression toward OA. Level of Evidence: Level IV, case series with no comparison group.

  • Open Access

    Hip Labral Reconstruction With a Synthetic Graft: Development and Preclinical Validation

    by Enrico Tassinari, Mauro Petretta, Giorgia Borciani, Luca Cristofolini, Eleonora Olivotto

    Objectives: Hip Osteoarthritis (OA) affects a significant component of the adult population, placing itself among the most important causes of disability and need for total hip replacement. Femoroacetabular impingement (FAI) is an anatomic alteration of the proximal femur and/or acetabulum leading to chondro‐labral damage and playing a prominent role in OA pathogenesis. Thus, treating FAI is fundamental to relieve hip pain and further joint tissue deterioration. Labral reconstruction is considered the treatment of choice, in particular using tendon allografts or autografts which, however, have some limitations. Here, we investigated the possibility to create a synthetic graft for labral reconstruction to best restore the load bearing and ready to be used in the surgical room. Methods: The graft was designed analyzing the anatomical structures from intact tissue samples. After a preliminary screening of different polymers, silicone was selected for its flexibility and elasticity to better adhere to the implantation site. We used an FDA‐approved biocompatible silicone (VK100), and a mold casting was selected as a fabrication method. Cytocompatibility of VK100 was tested in vitro with an immortalized chondrocytes human cell line (C‐28/I2). A cadaver lab was used to test the implantation procedure and to investigate the effects of the device transplantation on hip range of motion, translation, and resultant joint stability. To test the long‐term strength of the reconstruction under cyclic loading, synthetic hemipelves were prepared for biomechanical testing and subjected to 10,000 cycles where deflections of up to 5 mm were imposed. Results: In vitro tests showed that up to 14 days of culture C‐28/I2 cells were alive and adherent to VK100 surface with the formation of cell protrusions. As for cell cytotoxicity, a slight increase in LDH levels was observed at 14 days, probably due to the high confluence of adherent cells. We also demonstrated with the ex vivo procedure on cadaver that the device was suitable for arthroscopic implantation without damage or structural compromise during fixation to the acetabular bone. The range of motion and joint stability were preserved after implantation. Furthermore, the graft reconstruction successfully passed strenuous biomechanical cyclic loading. The force peak decreased by less than 10% during the test, indicating no detectable reduction of stiffness nor displacement/failure of the graft. No sign of damage was observed after test completion. Conclusions: Overall, these results suggest that we have developed a functional synthetic graft that might be quickly transferred to clinical practice.


  • Open Access

    Post‐operative injection of hydrolyzed collagen peptides shows anti‐inflammatory effect in patients with femoroacetabular impingement improving the early recovery

    by Enrico Tassinari, Andrea Minerba, Tommaso Basile, Alessio Bucciarelli, Francesco Traina, Brunella Grigolo, Stefano Zaffagnini, Eleonora Olivotto

    Purpose: This study aimed to compare the use of cortisone (C), intra‐articular injected at the end of hip arthroscopy in patients with femoroacetabular impingement (FAI), to a new Class III medical device based on hydrolyzed collagen peptides ‘PEPTYS’ (P) and, to investigate potential associations among preoperative symptoms and hip function, outcomes after arthroscopic surgery and presence of inflammatory biomarkers in synovial fluids (SFs) at basal condition.Methods: The two treatments were administrated to patients scheduled for arthroscopy with simple blind randomization sampling. Based on the sample size calculation, the number necessary to recruit was at least 20 patients for the C group and 20 for the P group. SFs, when available, were obtained by aspiration just prior to surgical intervention. At the baseline, osteoarthritis (OA) severity was assessed with a radiographic scoring system (Tönnis classification). Physical examination and clinical assessment using the Hip disability and Osteoarthritis Outcome Score (HOOS) and visual analogue scale (VAS) score for pain were performed at the time of surgery and at 1 and 6 months of follow‐up. At the time of surgery, chondral (Outerbridge score) and labral pathology based on direct arthroscopic visualization were also evaluated.Results: Forty‐seven FAI patients were enroled, with a median age of 35 years with a standard deviation (SD) of 10.6 and a body mass index of 24.3kg/m² with an SD of 4.5. 24 patients were treated with C and 23 with P. Both treatments did not show any statistically significant difference in hip function and pain. High expression of inflammatory molecules in SFs was correlated with the worst post‐operative articular function.Conclusions: Our study showed that the use of P was completely comparable to cortisone. Therefore, PEPTYS might be a valuable candidate to improve early recovery, in terms of pain and function, from arthroscopic FAI treatment.Level of Evidence: Level III, comparative and randomized study.


  • Open Access

    Comparison of single taper and dual taper versions of the same stem design in total hip arthroplasty for primary osteoarthritis

    by Francesco Castagnini, Barbara Bordini, Monica Cosentino, Enrico Tassinari, Giulia Guizzardi, Francesco Traina

    Background: In total hip arthroplasty (THA), the outcomes of single taper (ST) and dual taper (DT) versions of the same stem design have been scarcely studied. A registry study comparing ST and DT versions of the same stem design was designed, aiming to assess: (1) the survival rates and the hazard ratios for failure; (2) the survival rates and the hazard ratios for failure using stem-focused endpoints. Material and methods: A regional arthroplasty registry was interrogated about stem designs with ST and DT versions in cementless THAs performed for primary osteoarthritis. Only the same cup and ceramic-on-ceramic bearings were included: the DT stems had a titanium-on-titanium modularity. Demographic and implant features were recorded. Survival rates and hazard ratios were evaluated and compared. Stem-focused endpoints were also investigated. Results: A total of 5359 THAs were included, with three stem designs. The two versions of every stem showed different demographics and implant-related features: ST versions were preferentially implanted in heavier young men. For each stem, the two versions had similar survival rates at 5 years (p = 0.076; p = 0.319; p = 0.616) and similar adjusted hazard ratios for failures (p = 0.084; p = 0.308; p = 0.729). When stem-focused endpoints were adopted, the ST and DT versions of the three stems achieved similar survival rates (p = 0.710; p = 0.784; p = 0.983) and similar adjusted hazard ratios (p = 0.647; p = 0.858; p = 0.787). Three neck breakages occurred (0.0007% of all the modular implants). Conclusions: ST and DT versions of the same stem design did not show any differences in terms of survival rates and hazard ratios for failures at 5 years. LEVEL OF EVIDENCE: IV.